Literature DB >> 29868319

Surgical Treatment of Olfactory Neuroblastoma: Major Complication Rates, Progression Free and Overall Survival.

Aileen Wertz1, Todd Hollon2, Lawrence J Marentette1,2,3, Stephen E Sullivan2, Jonathan B McHugh4, Erin L McKean1,2.   

Abstract

Objective  We aimed to compare major complication rates in patients undergoing open versus endoscopic resection of olfactory neuroblastoma (ONB) and to determine the prognostic utility of the Kadish staging and Hyams grading systems with respect to progression-free survival (PFS) and overall survival (OS). Methods  It is a retrospective review of experience in treating ONB at a single tertiary care hospital from 1987 through 2015. Major complications were defined as cerebrospinal fluid (CSF) leak, meningitis, osteomyelitis, tracheostomy, and severe neurologic injury. Results  Forty-one patients were included. An open approach was used in 34 (83%), endoscopic in 6 (15%), and combined in 1 (2%) case. Rates of major complications by surgical approach were 17% after endoscopic versus 31% after open ( p  = 0.65). There was no significant difference in PFS or OS based on Kadish B versus C (PFS, p  = 0.28; OS, p  = 0.11) or Hyams grade 1 and 2 versus Hyams grade 3 and 4 (PFS, p  = 0.53; OS, p  = 0.38). Conclusions  There was no significant difference in major complications between open and endoscopic approaches for the treatment of ONB. Patient stratification using the Kadish staging and Hyams grading systems did not show significant differences in PFS or OS. Further research is needed to determine if a different staging system would better predict patient outcomes.

Entities:  

Keywords:  Hyams; Kadish; complication; endoscopic; olfactory neuroblastoma; recurrence; survival

Year:  2017        PMID: 29868319      PMCID: PMC5978851          DOI: 10.1055/s-0037-1605593

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  18 in total

1.  Endoscopic endonasal resection of esthesioneuroblastoma: A single center experience of 24 patients.

Authors:  Ling Feng; Jugao Fang; Luo Zhang; Huabin Li; Bing Zhou; Xiaohong Chen; Yunchuan Li; Demin Han
Journal:  Clin Neurol Neurosurg       Date:  2015-08-13       Impact factor: 1.876

Review 2.  Clinicopathological review: esthesioneuroblastoma.

Authors:  Taryn McFadden Bragg; Joseph Scianna; Amin Kassam; Bahman Emami; Henry G Brown; Lotfi Hacein-Bey; Joseph I Clark; Kamil Muzaffar; Nicholas Boulis; Vikram C Prabhu
Journal:  Neurosurgery       Date:  2009-04       Impact factor: 4.654

Review 3.  Esthesioneuroblastoma: a meta-analysis and review.

Authors:  P Dulguerov; A S Allal; T C Calcaterra
Journal:  Lancet Oncol       Date:  2001-11       Impact factor: 41.316

4.  Esthesioneuroblastoma: the University of Iowa experience 1978-1998.

Authors:  J H Simon; W Zhen; T M McCulloch; H T Hoffman; A C Paulino; N A Mayr; J M Buatti
Journal:  Laryngoscope       Date:  2001-03       Impact factor: 3.325

5.  Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.

Authors:  R C Miyamoto; L L Gleich; P W Biddinger; J L Gluckman
Journal:  Laryngoscope       Date:  2000-08       Impact factor: 3.325

6.  Esthesioneuroblastoma: the Johns Hopkins experience.

Authors:  V A Resto; D W Eisele; A Forastiere; M Zahurak; D J Lee; W H Westra
Journal:  Head Neck       Date:  2000-09       Impact factor: 3.147

7.  Esthesioneuroblastoma: prognosis and management.

Authors:  A Morita; M J Ebersold; K D Olsen; R L Foote; J E Lewis; L M Quast
Journal:  Neurosurgery       Date:  1993-05       Impact factor: 4.654

8.  Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.

Authors:  Jannis Constantinidis; Helmut Steinhart; Michael Koch; Michael Buchfelder; Anne Schaenzer; Manfred Weidenbecher; Heinrich Iro
Journal:  Otolaryngol Head Neck Surg       Date:  2004-05       Impact factor: 3.497

9.  Esthesioneuroblastoma: continued follow-up of a single institution's experience.

Authors:  Andrew H Loy; James F Reibel; Paul W Read; Christopher Y Thomas; Steven A Newman; John A Jane; Paul A Levine
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-02

10.  Esthesioneuroblastoma: the Northwestern University experience.

Authors:  Athanassios Argiris; Jose Dutra; Paraskevi Tseke; Kenneth Haines
Journal:  Laryngoscope       Date:  2003-01       Impact factor: 3.325

View more
  1 in total

Review 1.  Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review.

Authors:  Daniel B Spielman; Andi Liebowitz; Maeher Grewal; Chetan Safi; Jonathan B Overdevest; Alfred M Iloreta; Brett E Youngerman; David A Gudis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.